Global University Venturing

A range of new materials and technologies could yield vastly improved batteries for purposes including electric vehicles and grid storage.

Sector report: Energy

The following is a snapshot of the data we have collected on investment activity over the past three months. To verify reported deals, we contact about 300 corporate investors each quarter – these comprise roughly 18% of the global CVCs we cover, but account for most of the deals that are made public.

Johns Hopkins oncology diagnostics spinout PGDx had previously raised approximately $99m.

Sun protection product developer Nanosive has been launched by Truffle Capital with a licence from Yale University.

The newly-founded Oxford cardiovascular imaging spinout raised seed funding from backers including Oxford Sciences Innovation to pursue further product development.

Université libre de Bruxelles has added a fourth Theodorus fund to its arsenal with an initial close of $23m and a target of up to $33.5m.

Bsense Bio Therapeutics has emerged from stealth with a round of undisclosed size that involved Takeda Ventures and Johnson & Johnson Innovation–JJDC.

The UCL Technology Fund is in line for an exit from gene therapy developer Orchard Therapeutics, which has raised more than $290m in equity funding.

OmniSci, formerly known as MapD and based on research at MIT, has added $55m to its coffers thanks to investors including Nvidia and Verizon, bringing its total funding to $92m.